Clinical trial
HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in…
NCT00215839 · Hepatitis Resource Network, Other · Unknown status
Key facts
| NCT number | NCT00215839 |
|---|---|
| Title | HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy |
| Official title | A Multi-Center, Randomized, Open-Label, Phase IIIb Study Investigating the Safety and Efficacy of Peginterferon a-2a Plus Ribavirin for the Treatment of Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon… |
| Lead sponsor | Hepatitis Resource Network, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C Infection in HIV Infected Persons, HIV Infections |
| Intervention type | Drug |
| Interventions | Peginterferon a-2a plus Ribavirin |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 25, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: